Anti-MUC1 nano-aptamers for triple-negative breast cancer imaging by single-photon emission computed tomography in inducted animals: initial considerations

References

• GLOBOCAN 2012: cancer incidence and mortality worldwide in 2012 – IARC2012 Available from: http://globocan.iarc.fr/Pages/fact_sheets_population.aspxAccessed October 10, 2016
   Google Scholar
• ChappuisPRosenblattJFoulkesWThe influence of familial and hereditary factors on the prognosis of breast cancerAnn Oncol199910101163117010586331
   PubMedGoogle Scholar
• SorlieTMolecular portraits of breast cancer: tumors subtypes as distinct disease entitiesEur J Cancer200440182667267515571950
   PubMed Web of Science ®Google Scholar
• JemalACenterMMWardEThunMJCancer occurrenceMethods Mol Biol200947132919109772
   PubMedGoogle Scholar
• CareyLAPerouCMLivasyCARace, breast cancer subtypes, and survival in the Carolina Breast Cancer StudyJAMA200629521249250216757721
   PubMed Web of Science ®Google Scholar
• Reis-FilhoJSWestburyCPiergaJYThe impact of expression, profiling on prognostic and predictive testing in breast cancerJ Clin Pathol200659322523116505270
   PubMedGoogle Scholar
• DeSantisCMaJBryanLJemalABreast cancer statistics, 2013CA Cancer J Clin2014641526224114568
   PubMed Web of Science ®Google Scholar
• ChabalierCLamareCRaccaCPrivatMValetteALarminatFBRCA1 down regulation leads to premature inactivation of spindle checkpoint and confers paclitaxel resistanceCell Cycle2006591001100716639080
   PubMed Web of Science ®Google Scholar
• JeffreySSFeroMJBørresen-DaleALBotsteinDExpression array technology in the diagnosis and treatment of breast cancerMol Interv20022210110914993355
   PubMedGoogle Scholar
• DongMHowTKirkbrideKCThe type IIITGF-β receptor suppresses breast cancer progressionJ Clin Invest200711720621717160136
   PubMed Web of Science ®Google Scholar
• GenderSJSpicerAPEpithelial mucin genesAnnu Rev Physiol1995576076347778880
   PubMedGoogle Scholar
• GenderSJMUC1, the renaissance moleculeJ Mammary Gland Biol Neoplasia20016333935311547902
   PubMedGoogle Scholar
• GirlingABartkovaJBurchellJGendlerSGillettCTaylor-PapadimitriouJA core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomasInt J Cancer1989436107210762471698
   PubMed Web of Science ®Google Scholar
• HoSBNiehansGALyftogtCHeterogeneity of mucin gene expression in normal and neoplastic tissuesCancer Res1993536416517678777
   PubMed Web of Science ®Google Scholar
• ZhangYMLiuNZhuZHRusckowskiMHnatowichDJInfluence of different chelators (HYNIC, MAG3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled antisense DNAEur J Nucl Med200027111700170711105827
   PubMedGoogle Scholar
• Taylor-PapadimitriouJBurchellJMilesDWDalzielMMUC1 and cancerBiochim Biophys Acta199914552–330131310571020
   PubMed Web of Science ®Google Scholar
• VladAMDiaconuIGanttKRMUC1 in endometriosis and ovarian cancerImmunol Res2006361–322923617337783
   PubMedGoogle Scholar
• FerreiraCSMMatthewsCMissailidisSDNA aptamers that bind to Muc1 tumour marker: design and characterization of Muc1-binding single stranded DNA aptamersTumour Biol200627628930117033199
   PubMedGoogle Scholar
• FerreiraCSMPapamichaelKGuilbaultGSchwarzacherTGariepyJMissailidisSDNA aptamers against Muc1: design of aptamer-antibody sandwich ELISA for early tumour diagnosisAnal Bioanal Chem2008390416182642
   Google Scholar
• ChopraAShuklaRSharmaTKAptamers as an emerging player in biologyAptamers Syn Antibodies201411111
   Google Scholar
• BorbasKEFerreiraCSPerkinsABruceJIMissailidisSDesign and synthesis of mono- and multimeric targeted radiopharmaceuticals based on novel cyclen ligands coupled to anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancerBioconjug Chem20071841205121217583928
   PubMedGoogle Scholar
• PieveCDPerkinsACMissailidisSAnti-Muc1 aptamers: radiolabelling with (99m)Tc and biodistribution in Mcf-7 tumour-bearing miceNucl Med Biol200936670371019647177
   PubMedGoogle Scholar
• Da PieveCBlackshawEMissailidisSPerkinsACPEGylation and biodistribution of an anti-MUC1 aptamer in MCF-7 tumor-bearing miceBioconjug Chem20122371377138122708500
   PubMedGoogle Scholar
• FerreiraCSCheungMCMissailidisSBislandSGariépyJPhototoxic aptamers selectively enter and kill epithelial cancer cellsNucleic Acids Res200937386687619103663
   PubMedGoogle Scholar
• HuYDuanJZhanQWangFLuXYangXDNovel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitroPLoS One201272e3197022384115
   PubMedGoogle Scholar
• SáLTSimmonsSMissailidisSda SilvaMISantos-OliveiraRAptamer-based nanoparticles for cancer targetingJ Drug Target201321542743423350808
   PubMed Web of Science ®Google Scholar
• YuCHuYDuanJNovel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitroPloS One20116e2407721912664
   PubMed Web of Science ®Google Scholar
• HamoudehMKamlehMADiabRFessiHRadionuclides delivery systems for nuclear imaging and radiotherapy of cancerAdv Drug Deliv Rev200860121329134618562040
   PubMed Web of Science ®Google Scholar
• RobilottaCecilCA tomografia por emissçao de pósitrons: uma nova modalidade na medicina nuclear brasileira. Ver Panam Salud Publica [Positron emission tomography: a new modality in Brazilian nuclear medicine]202/32006 Available from: http://journal.paho.org/uploads/1162234592.pdfAcesso em 05 de março de 2016 Portuguese
   Google Scholar
• ToninRSCintilografia e PET/CT nas neoplasias malignas [Scintigraphy and PET/CT in malignant neoplasms]Porto Alegre, Rio Grande do SulUFRS2011 Portuguese
   Google Scholar
• Santos-OliveiraRNanoradiopharmaceuticals: is that the future for nuclear medicine?Curr Radiopharm20114214014322191653
   PubMedGoogle Scholar
• SarcinelliMADesenvolvimento de Nanopartícula de Poli(Ácido Lático) contendo Anticorpo Monoclonal marcada com 99mTc para o Diagnóstico Precoce e Tratamento Eficaz do Câncer de Mama [Tese de D.Sc]Rio de Janeiro, RJIMA/UFRJ2014 Portuguese
   Google Scholar
• Albernaz M deSOspinaCARossiAMSantos-OliveiraRRadiolabelled nano hydroxyapatite with 99mTc: perspectives to nano radiopharmaceuticals constructionArtif Cells Nanomed Biotechnol2014422889123586417
   PubMedGoogle Scholar
• PintoSRSarcinelleMAde Souza AlbernazMIn vivo studies: comparing the administration via and the impact on the biodistribution of radiopharmaceuticalsNucl Med Biol201441977277425027865
   PubMedGoogle Scholar
• ZhouJSatheesanSLiHCell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivityChem Biol201522337939025754473
   PubMedGoogle Scholar
• BaekJSKimJHParkJSChoCWModification of paclitaxel-loaded solid lipid nanoparticles with 2-hydroxypropyl-b-ciclodextrin enhances absorption and reduces nephrotoxicity associated with intravenous injectionInt J Nanomedicine2015105397540526347363
   PubMed Web of Science ®Google Scholar
• XuFLiuFZhaoHAnGFengGPrognostic significance of MUC1 in various human epithelial cancer: a meta-analysisMedicine20159450e228626683959
   PubMedGoogle Scholar
• GouyerVDubuquoyLRobbe-MasselotCDelivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrierSci Rep20151559577
   Google Scholar
• KimGEBaeHIParkHUAberrant expression of MUC5AC and MUC6 gastric mucins and sialylTn antigen in intraepithelial neoplasm of the pancreasGastroenterology200212341052106012360467
   PubMedGoogle Scholar
• CorfieldAMyerscoughNLongmanRSylvesterPArulSPignatelliMMucins and mucosal protection in the gastrointestinal tract: news prospects for mucins in the phatology of gastrointestinal diseaseGut200047458959410986224
   PubMedGoogle Scholar
• LeeMJLeeHSKimWHChoiYYangMExpression of mucins and cytokeratins in primary carcinomas of the digestive systemMod Pathol200316540341012748245
   PubMed Web of Science ®Google Scholar
• AnselmoACGuptaVZernBJDelivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cellsACS Nano2013712111291113724182189
   PubMed Web of Science ®Google Scholar
• BlancoEShenHFerrariMNanoparticle rational design implementation for overcoming delivery barriersNat Biotechnol20153394195126348965
   PubMed Web of Science ®Google Scholar